P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Jevtana was FDA approved for the treatment of men who have become resistant to Taxotere. Its chemical structure is similar to Taxotere. We have witnessed men with dramatic clinical improvement in men with Taxotere resistant disease. The side effects of Jevtana are similar to Taxotere though there is a slightly higher incidence of diarrhea. Treatment is administered every three weeks.
Listen: https://soundcloud.com/prostate-oncology/pp-e008 Modern chemotherapy is much more tolerable and much more effective than what we previously had.” – Dr. Scholz For many people the word chemotherapy triggers a lot of …
How to Sequence Taxotere, Jevtana, Xtandi, and Zytiga By Mark Scholz, MD Since the advent of effective second-generation hormonal therapies such as Zytiga or Xtandi, prostate cancer experts have been …
BY MARK SCHOLZ, MD Selecting treatment for prostate cancer is complex. Start by taking the Staging Quiz (keytopc.com). This is the first-step to understanding proper management. Once you know your …
BY MARK SCHOLZ, MD New prostate cancer drugs come to market quite rarely because the studies mandated by the FDA cost hundreds of millions of dollars. The FDA requires these studies to randomly allocate men into …
BY MARK SCHOLZ, MD Metastases are what makes cancer dangerous. Uncontrolled cell growth disrupts normal organ function. Some organs, like lymph nodes for example, continue to function well, even when the cancer …